The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (ASE:JPHM)

Jordan · Delayed Price · Currency is JOD

1.480

-0.010 (-0.67%)

At close: Apr 20, 2026

ASE:JPHM Income Statement

Financials in millions JOD. Fiscal year is January - December.

Millions JOD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	24.46	16.86	14.58	16.96	15.83	14.92
Revenue Growth (YoY)	63.74%	15.65%	-14.03%	7.16%	6.12%	49.49%
Cost of Revenue	12.06	9.78	11.01	10.11	10.79	9.93
Gross Profit	12.4	7.08	3.57	6.86	5.04	4.99
Selling, General & Admin	5.89	5.76	4.99	5.44	7.21	7.95
Research & Development	0.34	0.36	0.48	0.47	0.41	-
Amortization of Goodwill & Intangibles	0.06	0.06	0.04	0.04	0.03	0.04
Other Operating Expenses	0.61	0.61	0.06	0.42	-	-
Operating Expenses	6.9	6.79	5.58	7.73	7.65	7.98
Operating Income	5.5	0.29	-2.01	-0.88	-2.61	-2.99
Interest Expense	-0.3	-0.39	-0.65	-1.32	-0.93	-1.48
Earnings From Equity Investments	0.84	1.51	0.23	1.26	-0.11	0.15
Currency Exchange Gain (Loss)	-	-	-0.08	-0.06	-0	-0.02
Other Non Operating Income (Expenses)	-0.12	-0.34	-0.13	0.18	0.01	0.01
EBT Excluding Unusual Items	5.92	1.06	-2.63	-0.83	-3.64	-4.33
Gain (Loss) on Sale of Assets	-	-	-	-0.03	-	0.02
Asset Writedown	-0.06	-0.08	-0.07	-0.07	-0.07	-0.09
Legal Settlements	-	-	-	-	2.83	-5.67
Other Unusual Items	-	-	-	-	1.03	0.49
Pretax Income	5.87	0.98	-2.71	-0.92	0.15	-9.58
Income Tax Expense	1	0.34	0.14	-1.14	0.06	2.1
Earnings From Continuing Operations	4.87	0.64	-2.85	0.22	0.09	-11.68
Minority Interest in Earnings	-0	0.01	-0	0	0.03	0.05
Net Income	4.86	0.65	-2.86	0.22	0.12	-11.64
Net Income to Common	4.86	0.65	-2.86	0.22	0.12	-11.64
Net Income Growth	-	-	-	79.58%	-	-
Shares Outstanding (Basic)	34	34	34	69	69	25
Shares Outstanding (Diluted)	34	34	34	69	69	25
Shares Change (YoY)	-51.69%	-	-50.83%	-	170.77%	-
EPS (Basic)	0.14	0.02	-0.08	0.00	0.00	-0.46
EPS (Diluted)	0.14	0.02	-0.08	0.00	0.00	-0.46
EPS Growth	-	-	-	79.56%	-	-
Free Cash Flow	4.26	0.98	0.4	-6.59	-0.32	-9.66
Free Cash Flow Per Share	0.13	0.03	0.01	-0.10	-0.01	-0.38
Gross Margin	50.68%	42.00%	24.51%	40.42%	31.85%	33.45%
Operating Margin	22.48%	1.71%	-13.77%	-5.17%	-16.48%	-20.07%
Profit Margin	19.88%	3.86%	-19.59%	1.29%	0.77%	-78.02%
Free Cash Flow Margin	17.43%	5.82%	2.75%	-38.88%	-2.02%	-64.79%
EBITDA	6.13	1.08	-1.41	-0.37	-2.19	-2.56
EBITDA Margin	25.05%	6.41%	-9.66%	-2.19%	-13.82%	-17.13%
D&A For EBITDA	0.63	0.79	0.6	0.51	0.42	0.44
EBIT	5.5	0.29	-2.01	-0.88	-2.61	-2.99
EBIT Margin	22.48%	1.71%	-13.77%	-5.17%	-16.47%	-20.07%
Effective Tax Rate	17.05%	34.57%	-	-	37.93%	-
Advertising Expenses	-	0.24	0.1	0.14	0.32	0.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.